MiRNA-98 inhibits ovarian carcinoma cell proliferation, migration and invasion via targeting SALL4

Minerva Med. 2021 Feb;112(1):154-155. doi: 10.23736/S0026-4806.19.06179-2. Epub 2019 Jul 5.

Authors

Zhenjie Wang¹, Yan Han², Xia Xing², Caixia Jiang³, Hong Guo⁴, Yun Guan⁵

Affiliations

¹ Medical Records Room, Weifang People's Hospital, Weifang, China.
² Department of Obstetrics, The People's Hospital of Zhangqiu Area, Jinan, China.
³ Department of Endocrinology, The People's Hospital of Zhangqiu Area, Jinan, China.
⁴ Health Management Center, The People's Hospital of Zhangqiu Area, Jinan, China.
⁵ Department of Respiratory Medicine, Weifang People's Hospital, Weifang, China - cfa263283@163.com.

PMID: 31282134
DOI: 10.23736/S0026-4806.19.06179-2

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Ovarian Epithelial / metabolism*
Carcinoma, Ovarian Epithelial / pathology
Cell Line, Tumor
Cell Movement*
Cell Proliferation*
Down-Regulation
Female
Humans
Luciferases / metabolism
MicroRNAs / genetics
MicroRNAs / metabolism*
Neoplasm Invasiveness
Neoplasm Proteins / metabolism
Ovarian Neoplasms / metabolism*
Ovarian Neoplasms / pathology
Ovary / metabolism
Ovary / pathology
Transcription Factors / metabolism*

Substances

MIRN98 microRNA, human
MicroRNAs
Neoplasm Proteins
SALL4 protein, human
Transcription Factors
Luciferases